Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM) Meeting Abstract

  

Authors:	Holstein, S. A.; Owzar, K.; Richardson, P. G.; Jiang, C.; Hofmeister, C. C.; Hassoun, H.; Hurd, D. D.; Stadtmauer, E. A.; Giralt, S.; Devine, S. M.; Hars, V.; Postiglione, J. R.; Weisdorf, D. J.; Vij, R.; Moreb, J. S.; Callander, N. S.; Martin, T. G.; Shea, T. C.; Anderson, K. C.; McCarthy, P. L.
Abstract Title:	Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM)
Meeting Title:	51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036901835
PROVIDER:	wos
DOI:	10.1200/jco.2015.33.15_suppl.8523
Notes:	Meeting Abstract: 8523 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80455